FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves an original ANDA for dihydroergotamine mesylate from Hikma Pharmaceuticals USA Inc., enabling generic availability for migraine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dihydroergotamine mesylate (Dihydroergotamine Mesylate)

Snippet

ORIG AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)